GlassScriptPhysician profile
Eduardo E Fernandez
NPI 1174589493
$1,075.22
in general payments reported to CMS, 2019-2025
21 companies · $177 in 2025
The $177 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $147 · 2020: $86.96 · 2022: $246 · 2024: $419 · 2025: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $511 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $511.10 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $200.98 | 2020-2025 | Zynyz |
| Jazz Pharmaceuticals INC. | $153.30 | 2024 | |
| Secura Bio, INC. | $134.92 | 2022 | |
| Karyopharm Therapeutics INC. | $110.64 | 2022 | |
| Astellas Pharma US INC | $85.05 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $79.99 | 2019-2025 | Calquence, Lynparza, Enhertu |
| Bayer Healthcare Pharmaceuticals INC. | $44.17 | 2024 | |
| Novartis Pharmaceuticals Corporation | $34.71 | 2019-2020 | |
| Novocure INC. | $27.71 | 2024 | Optune |
| Genentech USA, INC. | $25.90 | 2019 | |
| Daiichi Sankyo INC. | $22.95 | 2024 | Enhertu |
| Servier Pharmaceuticals LLC | $18.93 | 2025 | |
| Pfizer INC. | $18.80 | 2024 | |
| Sobi, INC | $18.01 | 2024 | |
| Abbvie INC. | $16.69 | 2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $14.76 | 2019 | |
| Rigel Pharmaceuticals, INC. | $14.44 | 2019 | |
| Mylan Institutional INC. | $14.33 | 2019 | |
| Janssen Biotech, INC. | $13.77 | 2019 | |
| Shire North American Group INC | $13.33 | 2019 | |
| Lilly USA, LLC | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eduardo Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.